Covered recipient · General Payments record
NATHAN L MCGINNIS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,515.46
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $465.51 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $237.03 | 15 |
| Abbott Laboratories | $81.33 | 4 |
| Astellas Pharma US Inc | $66.51 | 3 |
| GlaxoSmithKline, LLC. | $31.16 | 2 |
| Amgen Inc. | $16.62 | 1 |
| PFIZER INC. | $16.59 | 1 |
| DEXCOM, INC. | $16.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.60 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125356199 | CMS |
| Abbott Laboratories | $17.82 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125356201 | CMS |
| Abbott Laboratories | $19.40 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125356203 | CMS |
| Abbott Laboratories | $21.51 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125356205 | CMS |
| Amgen Inc. | $16.62 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115918725 | CMS |
| Astellas Pharma US Inc | $19.01 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139339756 | CMS |
| Astellas Pharma US Inc | $23.72 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369857 | CMS |
| Astellas Pharma US Inc | $23.78 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139372869 | CMS |
| Dexcom, Inc. | $16.27 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153324957 | CMS |
| GlaxoSmithKline, LLC. | $17.36 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115724090 | CMS |
| GlaxoSmithKline, LLC. | $13.80 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116253113 | CMS |
| Novo Nordisk Inc | $14.81 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096640969 | CMS |
| Novo Nordisk Inc | $14.03 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097505484 | CMS |
| Novo Nordisk Inc | $13.08 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097431205 | CMS |
| Novo Nordisk Inc | $13.54 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097647189 | CMS |
| Novo Nordisk Inc | $12.88 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097237335 | CMS |
| Novo Nordisk Inc | $12.77 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096921910 | CMS |
| Novo Nordisk Inc | $14.31 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097158104 | CMS |
| Novo Nordisk Inc | $12.88 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097742976 | CMS |
| Novo Nordisk Inc | $19.67 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573384 | CMS |
| Novo Nordisk Inc | $14.26 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096592436 | CMS |
| Novo Nordisk Inc | $20.37 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096645016 | CMS |
| Novo Nordisk Inc | $14.01 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096840936 | CMS |
| Novo Nordisk Inc | $21.73 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096940546 | CMS |
| Novo Nordisk Inc | $21.73 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097059009 | CMS |
| Novo Nordisk Inc | $16.96 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097737530 | CMS |
| PFIZER INC. | $16.59 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131204994 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.